✦ LIBER ✦

Postwash Retention of Iodoantipyrine in Carbon-14 Double-Label Autoradiography

✍ Scribed by Tanaka, Kortaro; Gotoh, Fumio; Gomi, Shintaro; Takashima, Shutaro; Mihara, Ban

Book ID: 109869904
Publisher: Nature Publishing Group
Year: 1987
Tongue: English
Weight: 112 KB
Volume: 7
Category: Article
ISSN: 0271-678X
DOI: 10.1038/jcbfm.1987.76

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

re: Postwash Retention of Iodoantipyrine

re: Postwash Retention of Iodoantipyrine in Carbon-14 Double-Label Autoradiography

✍ Ginsberg, Myron D.; Smith, David W.; Watson, Brant D.; Busto, Raul 📂 Article 📅 1987 🏛 Nature Publishing Group 🌐 English ⚖ 81 KB

Simultaneous Determination of Local Cere

Simultaneous Determination of Local Cerebral Glucose Utilization and Blood Flow by Carbon-14 Double-Label Autoradiography: Method of Procedure and Validation Studies in the Rat

✍ Ginsberg, Myron D.; Smith, David W.; Wachtel, Mitchell S.; Gonzalez, Mayra; Bust 📂 Article 📅 1986 🏛 Nature Publishing Group 🌐 English ⚖ 894 KB

Tissue Disposition of Carbon Disulfide.

Tissue Disposition of Carbon Disulfide. II. Whole-Body Autoradiography of 35S- and 14C-labelled Carbon Disulfide in Pregnant Mice

✍ Danielsson, Bengt R. G. ;Bergman, Kerstin ;D'Argy, Roland 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 699 KB

Tissue Disposition of Carbon Disulfide:

Tissue Disposition of Carbon Disulfide: I. Whole-body Autoradiography of 35S- and 14C-labelled Carbon Disulfide in Adult Male Mice

✍ Bergman, Kerstin ;Danielsson, Bengt R. G. ;D'Argy, Roland 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 810 KB

A novel method for the synthesis of carb

A novel method for the synthesis of carbon-14-labeled N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]propanamide and its use in quantitative whole-body autoradiography studies

✍ William J. Wheeler; Sylvia H. Chay; Jennifer L. Herman; Douglas D. O'Bannon 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 183 KB 👁 1 views

## Abstract Sumitriptan (1), a non‐selective 5‐HT~1B/1D~ agonist is an effective therapeutic agent for the acute treatment of migraine, but it is contraindicated for use in patients with known heart disease. The first Selective Serotonin One F Receptor Agonist (SSOFRA), 5‐(4′‐fluorobenz‐amido)‐3‐(_